clopidogrel and vonoprazan

clopidogrel has been researched along with vonoprazan in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Furuta, T; Hamaya, Y; Iwaizumi, M; Kagami, T; Miyajima, H; Osawa, S; Sugimoto, K; Suzuki, T; Umemura, K; Uotani, T; Yamade, M1
Czerniak, R; Nishihara, M1
Furuta, T; Kagami, T1
Nishihara, M1
Furuta, T; Hamaya, Y; Higuchi, T; Iwaizumi, M; Kagami, T; Osawa, S; Sugimoto, K; Takahashi, S; Tamura, S; Tani, S; Uotani, T; Yamade, M1

Trials

1 trial(s) available for clopidogrel and vonoprazan

ArticleYear
Influence of daily versus alternate-day dosing of vonoprazan on intragastric pH, serum gastrin, and the antiplatelet function of clopidogrel : Influence of alternate-day dosing of vonoprazan.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:6

    Topics: Clopidogrel; Cross-Over Studies; Gastrins; Humans; Hydrogen-Ion Concentration; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Pyrroles; Sulfonamides

2022

Other Studies

4 other study(ies) available for clopidogrel and vonoprazan

ArticleYear
Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype.
    Clinical pharmacology and therapeutics, 2018, Volume: 103, Issue:5

    Topics: Adult; Asian People; Blood Platelets; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Female; Genotype; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrroles; Sulfonamides; Young Adult

2018
CYP-Mediated Drug-Drug Interaction Is Not a Major Determinant of Attenuation of Antiplatelet Function of Clopidogrel by Vonoprazan.
    Clinical pharmacology and therapeutics, 2018, Volume: 104, Issue:1

    Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Genotype; Prasugrel Hydrochloride; Pyrroles; Sulfonamides

2018
Response to "CYP-Mediated Drug-Drug Interaction Is Not a Major Determinant of Attenuation of Antiplatelet Function of Clopidogrel by Vonoprazan".
    Clinical pharmacology and therapeutics, 2018, Volume: 104, Issue:1

    Topics: Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Genotype; Prasugrel Hydrochloride; Pyrroles; Sulfonamides

2018
Inhibitory Effect of Vonoprazan on the Metabolism of [
    European journal of drug metabolism and pharmacokinetics, 2019, Volume: 44, Issue:5

    Topics: Clopidogrel; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Microsomes, Liver; Piperazines; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrroles; Sulfonamides

2019